Amendment No.2 Statement of Work No. TwoStatement of Work • November 8th, 2018 • HTG Molecular Diagnostics, Inc • Laboratory analytical instruments
THIS AMENDMENT No. 2 (hereinafter "Amendment 2") to Statement of Work No. Two is effective as of August 14, 2018 (the "Amendment 2 Effective Date") by and between HTG Molecular Diagnostics, Inc. ("HTG") and QIAGEN Manchester Limited ("QIAGEN").
AMENDMENT No. 2 TO SUPPLEMENT AGREEMENTSupplement Agreement • November 8th, 2018 • HTG Molecular Diagnostics, Inc • Laboratory analytical instruments
This Amendment No. 2 To Supplement Agreement ("Amendment 2") is effective July 2, 2018 ("Amendment 2 Effective Date") and is made by and between QIAGEN Manchester Limited, (“QIAGEN"), HTG Molecular Diagnostics, Inc., ("HTG”) and Bristol-Myers Squibb Company (“BMS").
Amendment No. 1 to Statement of Work No. TwoStatement of Work • November 8th, 2018 • HTG Molecular Diagnostics, Inc • Laboratory analytical instruments
THIS AMENDMENT No. 1 (hereinafter “Amendment 1”) to Statement of Work No. Two is effective as of July 2, 2018 (the “Amendment 1 Effective Date”) by and between HTG Molecular Diagnostics, Inc. (“HTG”) and QIAGEN Manchester Limited (“QIAGEN”).
Amendment No. 3 to Statement of Work No. TwoStatement of Work • November 8th, 2018 • HTG Molecular Diagnostics, Inc • Laboratory analytical instruments
THIS AMENDMENT No. 3 (hereinafter "Amendment 3") to Statement of Work No. Two is effective as of September 27, 2018 (the "Amendment 3 Effective Date") by and between HTG Molecular Diagnostics, Inc. ("HTG") and QIAGEN Manchester Limited (“QIAGEN").
